Physician profile

Jonathan S Sussman

Clinical Cardiac Electrophysiology · Morristown, NJ

NPI 1194779801

$40,695.03

in general payments reported to CMS, 2019-2025

33 companies · $5,285 in 2025

The $5,285 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

See the full distribution for Clinical Cardiac Electrophysiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$11,847.96
Travel and Lodging$7,622.85
Consulting Fee$2,624.25

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Biosense Webster, INC. $20,638.43 2019-2025 Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter
Abbott Laboratories $7,537.37 2019-2025 Aveir, Amplatzer Amulet, Jot Dx
Medtronic, INC. $3,467.13 2021-2025 Pulseselect, Cobalt Dr Mri Surescan, Micra
Boston Scientific Corporation $2,417.85 2019-2025 Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd
Aop Health US, LLC $1,249.02 2025 Rapiblyk
Medtronic Vascular, INC. $1,176.76 2019-2020
Acutus Medical, INC. $595.27 2020-2023
Cardiva Medical, INC. $574.44 2021-2025 Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f
Irhythm Technologies, INC. $395.56 2019-2024 Zio Xt Patch, Zio Monitor
Janssen Pharmaceuticals, INC $350.98 2019-2024 Xarelto
Sanofi-Aventis U.S. LLC $350.17 2019-2024
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $344.83 2019-2024 Lifevest
E.R. Squibb & Sons, L.L.C. $222.06 2019-2025 Eliquis, Camzyos
Kestra Medical Technology Services, INC. $219.47 2024-2025 Assure Wcd
Baxter Healthcare $203.61 2023-2025 Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Pfizer INC. $165.47 2022-2025
Atricure, INC. $139.05 2019-2024
Amgen INC. $92.15 2019-2025
Volta Medical INC $74.96 2024 Vx1
Siemens Medical Solutions USA, INC. $73.49 2022
Biotronik INC. $61.28 2021-2025 Acticor 7 Vr-T Dx
Bardy Diagnostics, INC. $52.00 2019-2021
Impulse Dynamics (USA) INC. $50.87 2022-2024 Optimizer
Alnylam Pharmaceuticals INC. $36.90 2024 Onpattro
Cordis US Corp. $35.26 2024 Mynx Venous Vcd
Ethicon US, LLC $31.25 2019
Penumbra, INC. $29.00 2024 Indigo System
Philips North America LLC $27.65 2024 (5044) Mcot
Becton, Dickinson and Company $27.24 2024 Hemosphere
Portola Pharmaceuticals, LLC $15.39 2019
Boehringer Ingelheim Pharmaceuticals, INC. $15.00 2019
Edwards Lifesciences Corporation $12.97 2023 Hemosphere
Medtronic USA, INC. $12.15 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jonathan S Sussman

$40,695.03

in general payments reported 2019-2025

Years
2019-2025
Top company
Biosense Webster, INC.
Context
The $5,285 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/99192/jonathan-s-sussman

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.